Molecular diagnostic testing in non-small cell lung cancer. Am J Hematol Oncol. 2014;10(4):4-11.Naidoo J M, Drilon A (2014) Molecular diagnostic testing in non-small cell lung cancer. Am J Hematol Oncol. Available on http://www.gotoper.com/publications/ajho/2014/2014sep/ molecular...
用于测定非小细胞肺癌预后的诊断方法 Diagnostic methods for determining the prognosis of non-small cell lung cancer用于测定非小细胞肺癌预后的诊断方法 Diagnostic methods for determining the prognosis of non-small cell lung cancer本公开内容提供了用于测定非小细胞肺癌预后的诊断方法和用于鉴定早期非小细胞肺癌(...
Abbreviations AE, adverse event; FFPE, formalin-fixed, paraffin-embedded; GI, gastrointestinal; HR, hazard ratio; IC, immune cell; IHC, immunohistochemistry; MHC, major histocompatibility complexes; NSCLC, non-small cell lung cancer; OR, odds ratio; ORR, overall response rate; OS, overall ...
EP: 1.Optimal Molecular Testing Practices in Non–Small Cell Lung Cancer EP: 2.Real-World Data and Barriers to Use of Molecular Testing in NSCLC EP: 3.Use of Molecular Profiling in Early-Stage Non–Small Cell Lung Cancer EP: 4.Molecular Testing in Advanced-Stage NSCLC: Use of Liquid Bi...
Non-small cell lung cancer (NSCLC) presents the greatest number of identified therapeutic targets, some of which have therapeutic utility. Currently, detectingEGFR,BRAF,KRASandMETmutations,ALK,ROS1,NTRKandRETtranslocations, and PD-L1 expression in these patients is considered essential. The use of ...
Blood IDH1 Level as a Diagnostic Biomarker for Non-Small Cell Lung CancerBlood IDH1 Level as a Diagnostic Biomarker for Non-Small Cell Lung Cancer发表人: 健康管理专家 阅读量: 110人The diagnosis of non-small cell lung cancer (NSCLC) relies heavily on the availability of effective biomarkers. Re...
Several noninvasive imaging studies and invasive tests are available. Understanding the accuracy, advantages, and disadvantages of the available methods for staging non-small cell lung cancer is critical to decision-making.Methods: Test accuracies for the available staging studies were updated from the...
Diagnostic method for determining the prognosis of non-small cell lung cancer The present disclosure provides methods for identifying early stage non-small-cell lung cancer (NSCLC) patients who will have an unfavorable prognosis for the recurrence of lung cancer after surgical resection. The methods ...
The diagnostic value of non-small cell lung cancer combined detection of a variety of indicators DOI:10.3969/J.issn.1672-6790.2016.03.022 中文关键词:癌,非小细胞肺肿瘤标记,生物学癌症早期检测 英文关键词:Carcinoma,non-small-cell lungTumor markers,biologicalEarly detection of cancer 〖FL ...
DIAGNOSTIC METHODS FOR DETERMINING PROGNOSIS OF NO 优质文献 相似文献 参考文献The log odds of positive lymph nodes is superior to other measures for evaluating prognosis of non-small cell lung cancer Objective To evaluate the ability of the log odds of positive lymph nodes to predict prognosis in ...